Lipoxin compounds and their use in treating cell proliferative disorders

Details for Australian Patent Application No. 2003271275 (hide)

Owner The Brigham and Women's Hospital, Inc.

Inventors Serhan Charles N.

Agent Davies Collison Cave

Pub. Number AU-B-2003271275

Parent 71775

Filing date 18 December 2003

Wipo publication date 22 January 2004

Acceptance publication date 2 August 2007

International Classifications

C07C 57/52 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

A61K 31/202 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07C 57/03 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

C07C 57/46 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

C07C 57/68 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

Event Publications

15 January 2004 Complete Application Filed

22 January 2004 Application Open to Public Inspection

  Published as AU-B-2003271275

2 March 2006 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Brigham and Women's Hospital to The Brigham and Women's Hospital, Inc.

2 August 2007 Application Accepted

  Published as AU-B-2003271275

29 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003271276-Monovalent, multivalent and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor

2003271274-Compositions and methods for increasing bone mineralization